These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 25623974

  • 21. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
    Daliri M, Abbaszadegan MR, Bahar MM, Arabi A, Yadollahi M, Ghafari A, Taghehchian N, Zakavi SR.
    Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical significance of the BRAF V600E mutation in multifocal papillary thyroid carcinoma in Korea.
    Ahn HY, Chung YJ, Kim BS, Kang KH, Seok JW, Kim HS, Park SJ, Cho BY.
    Surgery; 2014 Apr; 155(4):689-95. PubMed ID: 24612623
    [Abstract] [Full Text] [Related]

  • 24. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAFV600E mutation.
    Lee YK, Park KH, Park SH, Kim KJ, Shin DY, Nam KH, Chung WY, Lee EJ.
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [Abstract] [Full Text] [Related]

  • 25. Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
    Kowalska A, Walczyk A, Kowalik A, Pałyga I, Trybek T, Kopczyński J, Kajor M, Chrapek M, Pięciak L, Chłopek M, Góźdź S, Kamiński G.
    Thyroid; 2016 Apr; 26(4):543-51. PubMed ID: 26889698
    [Abstract] [Full Text] [Related]

  • 26. [Study on the correlation between BRAF(V600E) mutation and lymphatic metastases in papillary thyroid cancer staged preoperativelv as N0].
    Gao Q, Zhang W, Wang N, Duan H, Zhou Y, Zhang W, Zhao D.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2048-52. PubMed ID: 27101676
    [Abstract] [Full Text] [Related]

  • 27. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
    Li C, Lee KC, Schneider EB, Zeiger MA.
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4559-70. PubMed ID: 23055546
    [Abstract] [Full Text] [Related]

  • 28. The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome.
    Russo M, Malandrino P, Nicolosi ML, Manusia M, Marturano I, Trovato MA, Pellegriti G, Frasca F, Vigneri R.
    Thyroid; 2014 Aug; 24(8):1267-74. PubMed ID: 24787545
    [Abstract] [Full Text] [Related]

  • 29. Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population.
    Liu S, Zhang B, Zhao Y, Chen P, Ji M, Hou P, Shi B.
    Int J Clin Exp Pathol; 2014 Aug; 7(10):6922-8. PubMed ID: 25400776
    [Abstract] [Full Text] [Related]

  • 30. BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.
    Fraser S, Go C, Aniss A, Sidhu S, Delbridge L, Learoyd D, Clifton-Bligh R, Tacon L, Tsang V, Robinson B, Gill AJ, Sywak M.
    World J Surg; 2016 Jul; 40(7):1618-24. PubMed ID: 27138882
    [Abstract] [Full Text] [Related]

  • 31. [The co-relation of BRAF V600E mutation and factors affecting occurrence and prognosis of papillary thyroid carcinoma].
    Wang J, Liu LT, Cui D, He L, Liu DG.
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr 08; 48(4):288-292. PubMed ID: 30955264
    [Abstract] [Full Text] [Related]

  • 32. Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.
    Zhang Z, Zhang X, Yin Y, Zhao S, Wang K, Shang M, Chen B, Wu X.
    BMC Cancer; 2022 Apr 27; 22(1):461. PubMed ID: 35473554
    [Abstract] [Full Text] [Related]

  • 33. Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.
    Krishnamurthy A, Ramshankar V, Murherkar K, Vidyarani S, Raghunandhan GC, Das A, Desai PB, Albert K.
    Indian J Cancer; 2017 Apr 27; 54(1):372-378. PubMed ID: 29199726
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.
    Kim BH, Kim IJ, Lee BJ, Lee JC, Kim IS, Kim SJ, Kim WJ, Jeon YK, Kim SS, Kim YK.
    Yonsei Med J; 2015 May 27; 56(3):634-40. PubMed ID: 25837167
    [Abstract] [Full Text] [Related]

  • 36. Associations of the BRAF V600E Mutation and PAQR3 Protein Expression with Papillary Thyroid Carcinoma Clinicopathological Features.
    Gao J, Ma XP, Deng FS, Jiang L, Jia WD, Li M.
    Pathol Oncol Res; 2020 Jul 27; 26(3):1833-1841. PubMed ID: 31758408
    [Abstract] [Full Text] [Related]

  • 37. The correlation of sodium iodide symporter and BRAF(V600E) mutation in classical variant papillary thyroid carcinoma.
    Yazgan A, Yıldırım N, Gözalan A, Gümüştaş S, Kılıçarslan A, Balci S, Aydın C, Ersoy R, Cakir B, Güler G.
    Ann Diagn Pathol; 2016 Jun 27; 22():58-62. PubMed ID: 27180062
    [Abstract] [Full Text] [Related]

  • 38. Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.
    Shi CL, Sun Y, Ding C, Lv YC, Qin HD.
    Genet Mol Res; 2015 Jul 03; 14(3):7377-85. PubMed ID: 26214416
    [Abstract] [Full Text] [Related]

  • 39. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
    Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ, Zhu QY.
    Cell Physiol Biochem; 2016 Jul 03; 38(2):763-76. PubMed ID: 26871894
    [Abstract] [Full Text] [Related]

  • 40. Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer?
    Nam JK, Jung CK, Song BJ, Lim DJ, Chae BJ, Lee NS, Park WC, Kim JS, Jung SS, Bae JS.
    Am J Surg; 2012 Apr 03; 203(4):436-41. PubMed ID: 21803329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.